Latest in News & Research
HPV Vaccine Will Have Modest Impact on Oropharynx Cancer Incidence by 2045
However, reductions in oropharynx cancer incidence should be seen among young and middle-aged adults
Has There Been a Drop in Opioid Prescriptions After Mohs Surgery?
Use of hydrocodone decreased from 2011 to 2020, while use of tramadol increased from 2009 to 2020
Is Delgocitinib Ointment an Effective Treatment for Pediatric Eczema?
Treatment well tolerated among pediatric patients with atopic dermatitis; improvement seen through 56 weeks of treatment
Incidence of Psoriatic Arthritis Up With More Severe Psoriasis
Incidence of psoriatic arthritis increases with increasing severity of psoriasis stratified by treatment severity surrogates
Human Papillomavirus Infection Tied to Preterm Birth Risk
Risk increased for both persistent and placental infection and for both spontaneous and all preterm births
Adjuvant Pembrolizumab Cuts Recurrence in Stage II Melanoma
Compared with placebo, pembrolizumab prolonged regression-free survival in resected high-risk stage IIB and IIC melanoma
Parents Increasingly Cite Safety Concerns in HPV Vaccine Refusal
Despite 79.9 percent increase in parent-reported safety concerns, there was a drop in HPV vaccine-related reported adverse reactions
How Effective is Sirolimus for Slow-Flow Vascular Malformations in Children?
Sirolimus does not impact volume changes detected on MRI scans, but does reduce pain, oozing, bleeding
How Does Environment Affect the Facial Cutaneous, Enteral Microbiome in Rosacea?
Individuals with rosacea have decrease in richness, evenness of the facial cutaneous microbiome and drop in abundance of
Isotretinoin Does Not Up Suicide Risk in Acne Patients
Patients with acne prescribed isotretinoin less likely to engage in suicidal behavior than those treated with antibiotics only or those in the general population
2007 to 2021 Saw Dermatologic Procedure Reimbursement Down
Reimbursement varied by procedure types, with increases for skin biopsy and shave removal, decreases for Mohs micrographic surgery
Israeli Data on COVID Boosters to Be Published This Week in Major Journal
New data out of Israel, to be published this week, could bolster the notion that a third booster shot of the COVID-19 vaccine significantly...
Data Doesn't Support Need for COVID-19 Vaccine Boosters: Experts
COVID-19 vaccine booster shots might not be needed for most people, according to a large international review.
The review -- conducted by a team...
Kids' Temporary Tattoos Can Harm Skin Function
to be fixed
SARS-CoV-2-Positive Household Members Up Infection Risk for HCWs
Exposure to positive household members linked to increased risk for infection for vaccinated health care workers
Mental Health Improved Following First Dose of COVID-19 Vaccine
Adults receiving the vaccine between December 2020 and March 2021 reported decreased mental distress following first dose
Is Watchful Waiting an Appropriate Approach for Basal Cell Carcinoma?
Estimated tumor diameter increase in one year 4.46 mm for those with at least an infiltrative/micronodular component
Are Biologic Agents Linked to Skin, Soft Tissue Infections?
Data show no increased risk for SSTIs with biologic agent use, but risk increased for biologic therapy with concomitant corticosteroid use
Patient-Reported Outcome Measures May Aid Psoriasis Treatment
Including patient-reported outcome measures in routine care may facilitate individualized treatment for psoriasis
Psoriasis Not Linked to Preclinical Markers of Dementia
After adjustment for confounders, psoriasis may be linked to lower risk for developing dementia
9.7 Percent of All U.S. Persons Uninsured in 2020
Slight decrease seen from 2019, but difference was not significant; 13.9 percent of adults and 5.1 percent of children uninsured in 2020
Odds of COVID-19 Hospitalization Lower After Vaccination
Compared with infected unvaccinated individuals, infected vaccinated individuals report almost all symptoms less frequently
Did the COVID-19 Pandemic Affect the Number of Diagnosed Skin Cancers?
In 2020, lower-than-expected proportion of melanomas diagnosed at stages 0 to IA; higher-than-expected percent diagnosed at stages IIC, III, IV
24 of 1274